Deutetrabenazine · more major-labeled pairs than Dopamine
SPL labels Dopamine + Deutetrabenazine as moderate; Dopamine 5 / Deutetrabenazine 2 in that band.
Mechanism on file: This drug lowers the amount of dopamine available in the brain. Taking it with other drugs that affect dopamine can increase the risk of serious movement-related side effects like stiffness or restlessness.
FDA SPL severity: Moderate
Dopamine + Deutetrabenazine · SPL mechanism field
This drug lowers the amount of dopamine available in the brain. Taking it with other drugs that affect dopamine can increase the risk of serious movement-related side effects like stiffness or restlessness.
Moderate band excerpt · Dopamine with Deutetrabenazine
7.4 Neuroleptic Drugs The risk of parkinsonism, NMS, and akathisia may be increased by concomitant use of AUSTEDO XR or AUSTEDO with dopamine antagonists or antipsychotics.
Dopamine · 28 SPL pairs (broader portfolio than Deutetrabenazine)
- Carbidopa/Levodopa moderate
- Digoxin moderate
- Tetrabenazine moderate
- Tranylcypromine moderate
Deutetrabenazine · 2 major-labeled pairs (vs Dopamine's 0)
- Norepinephrine moderate
- Bupropion minor
- Fluoxetine minor
- Paroxetine minor
FDA Drug Labels (SPL) via openFDA. Registry display only. Not medical advice.
Read our methodology - how this data is sourced, computed, and verified.